What does 2022 hold for the biopharma industry? Which companies can play at the forefront in terms of products as well as business? Covid-19 will continue to be a...
Danish companies Novozymes and Novo Nordisk Pharmatech are teaming up to develop technical enzymes to support biopharma processing. The companies aim to develop high...
Danish pharma Novo Nordisk has agreed to buy Dicerna Pharmaceuticals, offering $3.3 billion for the US biopharma and its ribonucleic acid interference (RNAi) platform.
Danish drugmaker Novo Nordisk has acquired Prothena’s clinical-stage stage antibody PRX004 and broader ATTR amyloidosis program, gaining full global rights to the...
15.06.2020
- Danish drugmaker Novo Nordisk has agreed to buy Corvidia Therapeutics, a privately held, US-based clinical-stage company focused on the research and development of transformative...
12.02.2020
- Novo Nordisk has announced it will spend 800 million Danish Kroner (DKK, about $117.4 million) to further upgrade its insulin production site at Kalundborg, Denmark. The site’s...
